Empowering The Athlete Within: Exercise Intelligence Partners with Supersapiens
Atlanta – 17 October 2023 /ENDURANCE SPORTSWIRE/ – Supersapiens, the world’s first glucose management system for athletes, is excited to announce its strategic partnership with Exercise Intelligence (EXI), an acclaimed health and exercise innovator. United in a shared vision, both entities aim to “awaken the athlete within everyone”, harnessing the power of state-of-the-art technology and holistic health expertise.
“The partnership with EXI marks an exciting chapter in our journey. As we continue to strive to help all athletes optimize performance, uniting with EXI helps amplify our mission, bringing insights to athletes everywhere,” remarked Phil Southerland, Supersapiens CEO and Founder. “Our collaboration signifies more than just a partnership; it’s a commitment to empower every individual to activate their true athletic potential.”
EXI’s mission is to help millions accelerate the achievement of their most challenging health goals by helping them elevate activity levels and activate their innate athleticism, regardless of their starting point. EXI recognizes that every person has a unique athlete within them, waiting to be unveiled; EXI’s approach integrates seamlessly with Supersapiens’ dedication to optimizing performance through scientific analytics and insights.
“Allying with Supersapiens aligns perfectly with our vision at EXI,” commented EXI CEO Grace McNamara. “Their groundbreaking ecosystem, combined with our personalized exercise program for health promises a transformative experience for all individuals on their journey to better health and fitness. We believe that together, we can redefine what it means to awaken the athlete within.”
Supersapiens is focused on using science with sport to help all athletes reach their highest potential. Their ecosystem, including the Supersapiens app, Supersapiens Energy Band, and Supersapiens Data Dashboard, integrates with a host of wearables and performance tools, including Apple Watch, select Wahoo and Garmin devices, TrainingPeaks, Nolio app, Apple Health, and more.
Powered by Abbott’s Libre Sense Glucose Sport Biosensor, Supersapiens is a pioneering solution that gives athletes a deeper understanding of the intricate relationship between glucose levels and energy. For more information on the extensive range of Supersapiens products and to purchase Abbott’s Libre Sense biosensor, visit www.supersapiens.com.
About Supersapiens
Supersapiens is aiming to be the most influential sports brand of the decade. They develop innovative insights around glucose that aim to unlock better performance and recovery by driving positive behavior changes. Abbott’s Libre Sense Glucose Sport Biosensor is intended for athletes to measure their glucose levels. When used with a compatible product, the biosensor allows athletes to correlate their glucose levels and their athletic performance. The Supersapiens system including Abbott’s Libre Sense Glucose Sport Biosensor is not intended for medical use and is not intended for use in screening, diagnosis, treatment, cure, mitigation, prevention, or monitoring of diseases, including diabetes.
About EXI
EXI is Exercise Intelligence – a Software as a Medical Device (SaMD), part of the emerging field of digital therapeutics, that supports professionals and employers to refer people to exercise appropriately, and people with long-term health conditions to safely increase their physical activity. It’s designed for up to 23 long-term physical and mental health conditions such as obesity, cardiovascular disease, diabetes, hypertension, stroke, asthma, COPD, depression, anxiety and stress. Fully regulated and bringing together behavior change science with the latest clinical evidence and physical activity guidelines, it delivers safe, scalable, measurable health interventions that are medically proven, achievable and simple to monitor. It also harnesses behavior change support and rewards to engage people in their program, drive adherence and support sustained physical activity.
